Search Results
Jun 03, 2026, 16:15 ET MILLER INDUSTRIES TO PRESENT AND HOST 1X1 INVESTOR MEETINGS AT THE 16TH ANNUAL EAST COAST IDEAS INVESTOR CONFERENCE ON JUNE 10TH & 11TH IN NEW YORK, NY
CHATTANOOGA, Tenn., June 3, 2026 /PRNewswire/ -- Miller Industries, Inc. (NYSE: MLR), the World's Largest Manufacturer of Towing and Recovery Equipment, today announced that Chief Executive Officer, William Miller II, and Chief Financial
More news about: Miller Industries, Inc.
May 28, 2026, 08:15 ET Solstice Raises Series A to Radically Accelerate Pharma Commercialization
enabling content to move from concept to MLR submission in under 48 hours and be market-ready in roughly 10 days. As a result, teams are producing nearly three times more high-quality, tasteful and effective content per quarter and reducing the average number of MLR reviews per asset from 3.2 rounds to 1.2
More news about: Solstice Health
May 22, 2026, 08:00 ET The Broken Command Center: New Doceree Survey Documents the Structural Cost of Pharma's Fragmented Marketing Stack
from a person — a rep, a colleague, a partner — not from a system. By the time the brand team mobilises, debates the cause, briefs the agency, runs MLR, and traffics the response, ten or more weeks have passed. That's ten weeks of competitor presence with the physicians the brand is paying to reach.Lagging
More news about: Doceree
May 18, 2026, 11:00 ET Anthill Cloud - an AI-Powered Content Excellence Platform for the US Life Sciences Market
are navigating some of the most complex content challenges in the industry: growing demand for personalized HCP communications, pressure to accelerate MLR approvals, and the need to scale omnichannel tactics without multiplying overhead.
More news about: Anthill A/S
May 18, 2026, 05:07 ET Shaman Launches Shaman Atlas to Convert Pharma's Approved Content Into Structured Data
Marketing Email, Landing Page, CLM, Graphs, Banners & Social), generative AI through Aurora, Shaman's agentic AI content creation assistant, MLR tooling (MLR X-Ray, MLR Compare, AutoAnnotate), content intelligence (Smart Content Cards, Content Hub, MagicSearch, MagicCopy) and content extraction through
More news about: Shaman
May 14, 2026, 10:00 ET Supreme Group Launches Supreme Intelligence FDE+, the First Forward Deployed Expert Model Built for Healthcare and Life Sciences
API key, Supreme Group deploys an AI-native expert who already lives in this world and is fluent in therapeutic science, regulatory environments, and MLR workflows. Each FDE+ arrives with the full power of Supreme Intelligence already in production behind them."The market doesn't need another consultant
More news about: Supreme Group
May 07, 2026, 17:30 ET Pharma Just Got Its Workday Moment: Doceree's Daily Command Defines a New $30 Billion Software Category
the fragmented software stack Daily Command is designed to consolidate — point tools for market research, HCP targeting, media planning, measurement, MLR workflow, CRM, competitive intelligence, and agency project management. The category Doceree is creating addresses, conservatively, the top quartile
More news about: Doceree
May 07, 2026, 17:15 ET 75 of Pharma's Most Senior Marketers Just Walked Away From a $12 Billion Tool Stack
spend of pharma's largest brand teams on this fragmented stack — research portals, targeting tools, media-planning platforms, measurement dashboards, MLR workflows, CRM, competitive intelligence, agency project management — is conservatively estimated at over $12 billion globally.The Makers' position,
More news about: Doceree
May 07, 2026, 17:00 ET Doceree Introduces Daily Command -- The System of Work for Pharma Brand Teams, Co-Built by 75 of the Industry's Most Senior Operators
run the workflow — segment a market, brief a campaign, draft an MLR submission, reconcile a measurement discrepancy — and hand the operator a decision, not a dashboard.The third is pharma-grade governance. MLR, HIPAA, GDPR, and the medical-legal review chain are built into
More news about: Doceree
May 06, 2026, 16:15 ET MILLER INDUSTRIES REPORTS 2026 FIRST QUARTER RESULTS
ShareCHATTANOOGA, Tenn., May 6, 2026 /PRNewswire/ -- Miller Industries, Inc. (NYSE: MLR) ("Miller Industries" or the "Company") today announced financial results for the first quarter ended March 31, 2026, and provided updates on its global
More news about: Miller Industries, Inc.
Apr 29, 2026, 16:15 ET MILLER INDUSTRIES TO ANNOUNCE FIRST QUARTER 2026 RESULTS ON WEDNESDAY MAY 6, 2026
CHATTANOOGA, Tenn., April 29, 2026 /PRNewswire/ -- Miller Industries, Inc. (NYSE: MLR) intends to release its results for the First Quarter ended March 31, 2026, on Wednesday, May 6, 2026, after market close. The Company will host a conference
More news about: Miller Industries, Inc.
Mar 19, 2026, 14:54 ET Arbital Health's 2026 Summit Sets the Future Agenda for Value-Based Care and Risk Contracting
by actuarial logic to continuously measure contract performance, forecast financial impact, and deliver actionable insights to drive down spend and MLR, improving patient outcomes while there is still time to act. Arbital Health is led by a best-in-class team of healthcare actuaries, engineers, and industry
More news about: Arbital Health
Mar 10, 2026, 11:45 ET Veeva Acquires Ostro, the Leading Brand Engagement Platform for Life Sciences
combination of conversational AI, semantic search, and industry-specific business rules and guardrails. Responses are 100% compliant and drawn from MLR-approved materials. Unlike other AI solutions, Ostro does not hallucinate or generate novel responses."AI has changed how people get information.
More news about: Veeva Systems
Mar 10, 2026, 11:45 ET Veeva Acquires Ostro, the Leading Brand Engagement Platform for Life Sciences
combination of conversational AI, semantic search, and industry-specific business rules and guardrails. Responses are 100% compliant and drawn from MLR-approved materials. Unlike other AI solutions, Ostro does not hallucinate or generate novel responses."AI has changed how people get information.
More news about: Veeva Systems
Mar 10, 2026, 11:45 ET Veeva adquire a Ostro, a principal plataforma de engajamento de marcas para Ciências da Vida
regras e limites de negócio específicos do setor. As respostas estão 100% em conformidade com as normas e foram extraídas de materiais aprovados pela MLR. Ao contrário de outras soluções de IA, o Ostro não imagina ou cria respostas novas."A IA mudou a forma como as pessoas obtêm informações. Não
More news about: Veeva Systems
Mar 10, 2026, 11:45 ET Veeva adquiere Ostro, la plataforma líder de interacción de marca en ciencias de la vida
lineamientos de negocios específicos para la industria. Las respuestas cumplen con las normativas al 100 % y son tomadas de material aprobado por la MLR. A diferencia de otras soluciones de IA, Ostro no alucina ni genera respuestas novedosas."La IA ha cambiado la forma en que la gente obtiene información.
More news about: Veeva Systems
Mar 10, 2026, 11:45 ET Veeva übernimmt mit Ostro die führende Brand Engagement Plattform für Life Sciences
branchenspezifischen Geschäftsregeln und Schutzmechanismen. Die Antworten sind zu 100 % gesetzeskonform und greifen ausschließlich auf Inhalte zurück, die den MLR-Freigabeprozess (Medical, Legal, Regulatory) durchlaufen haben. Im Gegensatz zu anderen KI-Lösungen halluziniert Ostro nicht und generiert keine neuartigen
More news about: Veeva Systems
Mar 10, 2026, 11:45 ET Veeva adquiere Ostro, la plataforma líder de interacción con marcas en ciencias biológicas
semántica y reglas y medidas de seguridad específicas del sector. Las respuestas cumplen al 100 % con la normativa y se basan en materiales aprobados por MLR. A diferencia de otras soluciones de IA, Ostro no genera respuestas novedosas ni alucinaciones."La IA ha transformado la forma en que las personas
More news about: Veeva Systems
Mar 10, 2026, 11:45 ET Veeva acquiert Ostro, la principale plateforme d'engagement des marques pour les sciences de la vie
l'industrie. Les réponses sont 100 % conformes et proviennent de documents approuvés par le processus de validation médicale, juridique et réglementaire (MLR). Contrairement à d'autres solutions d'IA, Ostro ne provoque pas d'hallucinations et ne génère pas de réponses inédites.« L'IA a modifié la manière
More news about: Veeva Systems
Mar 05, 2026, 10:00 ET Arbital Health Marks Rapid Market Adoption of Actuarial AI in Value-Based Care
drivers are most influencing performance across my portfolio of contracts?""What is my current PMPM and MLR by market and year?""Show me total cost of care, risk scores and MLR by provider."Merlin AI has over 80 actuarially developed starter-prompts to ensure users are getting
More news about: Arbital Health
Mar 04, 2026, 16:15 ET MILLER INDUSTRIES REPORTS 2025 FOURTH QUARTER AND FULL YEAR RESULTS
CHATTANOOGA, Tenn., March 4, 2026 /PRNewswire/ -- Miller Industries, Inc. (NYSE: MLR) ("Miller Industries" or the "Company") today announced financial results for the fourth quarter and full year ended December 31, 2025, and provided
More news about: Miller Industries, Inc.
Feb 26, 2026, 11:43 ET Mark Farrah Associates Analyzed the 2024 Medical Loss Ratio and Rebates Results
2024, Alabama led the country with nearly $182 million in MLR rebates, 2.23% of adjusted premiums.2024 MLR rebates paid for the Individual segment were $$1.18 billion, which is .74% of the $159 billion collected in premiums.MLR Rebates for the Small Group segment in 2024 were $274 million,
More news about: Mark Farrah Associates (MFA)
Feb 25, 2026, 16:15 ET MILLER INDUSTRIES TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2025 RESULTS ON WEDNESDAY MARCH 4, 2026
CHATTANOOGA, Tenn., Feb. 25, 2026 /PRNewswire/ -- Miller Industries, Inc. (NYSE: MLR) intends to release its results for the Fourth Quarter and Full Year ended December 31, 2025, on Wednesday, March 4, 2026, after market close. The Company
More news about: Miller Industries, Inc.
Feb 03, 2026, 09:00 ET Supreme Group Launches Supreme Intelligence: An End-to-End AI Platform Built for the Healthcare and Life Sciences Marketing Lifecycle
secure environment, empowering agency teams and clients to enhance every stage of the commercial process, from business strategy and messaging to MLR, activation, and measurement."Our fundamental promise to our clients is to solve complex business problems," said Tom Donnelly, CEO of Supreme
More news about: Supreme Group
Dec 10, 2025, 11:28 ET CXZONE VON ACTO ERHÄLT ZWEI AUSZEICHNUNGEN BEI DEN 2025 PHARMACEUTICAL TECHNOLOGY EXCELLENCE AWARDS
Pharmaceutical Technology. „Durch die Kombination von einfühlsamen, klinisch fundierten Simulationen mit der nahtlosen Integration aktueller, von der MLR genehmigter Inhalte hat sich ACTO als zukunftsorientierter Partner für den Life-Sciences-Sektor und als klarer Gewinner in den Kategorien „Innovation"
More news about: ACTO Technologies, Inc.